Stifel Financial
AQST icon

Stifel Financial’s Aquestive Therapeutics AQST Stock Holding History

Stifel Financial’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.51M Buy
361,903
+2,000
+0.6% +$8.42K ﹤0.01% 2294
2026
Q1 		$1.49M Sell
359,903
-9,825
-3% -$39.9K ﹤0.01% 2163
2025
Q4 		$2.39M Buy
369,728
+3,300
+0.9% +$20.6K ﹤0.01% 1809
2025
Q3 		$2.05M Sell
366,428
-7,800
-2% -$33.7K ﹤0.01% 1897
2025
Q2 		$1.24M Sell
374,228
-900
-0.2% -$2.58K ﹤0.01% 2187
2025
Q1 		$1.09M Sell
375,128
-23,433
-6% -$70.9K ﹤0.01% 2167
2024
Q4 		$1.42M Buy
398,561
+302,617
+315% +$1.4M ﹤0.01% 2020
2024
Q3 		$478K Sell
95,944
-301,538
-76% -$1.17M ﹤0.01% 2708
2024
Q2 		$1.03M Buy
397,482
+7,600
+2% +$25.4K ﹤0.01% 2140
2024
Q1 		$1.66M Buy
+389,882
New +$1.3M ﹤0.01% 1857

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Stifel Financial's AQST Position: Q2 2026 in Review

Stifel Financial increased its Aquestive Therapeutics (AQST) stake by 0.56% in Q2 2026, buying an estimated $8.42K and bringing the position to 361,903 shares worth $1.51M. The position accounts for ﹤0.01% of the portfolio, ranked #2294.

Stifel Financial first reported a position in AQST in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.39M in Q4 2025. 184 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

  • Stifel Financial held 361,903 shares of Aquestive Therapeutics worth $1.51M as of Q2 2026.
  • Stifel Financial bought 2,000 Aquestive Therapeutics shares in Q2 2026, an estimated $8.42K.
  • Aquestive Therapeutics made up ﹤0.01% of Stifel Financial's portfolio in Q2 2026, its #2294 holding.
  • Stifel Financial first reported a position in Aquestive Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • Stifel Financial's Aquestive Therapeutics position peaked at $2.39M in Q4 2025.
  • 184 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.